Amphastar pharma posts q3 adj earnings per share of $0.10

Amphastar pharmaceuticals reports financial results for the three months ended september 30, 2019.q3 revenue $80.1 million versus refinitiv ibes estimate of $78.5 million.q3 gaap earnings per share $0.03.q3 earnings per share estimate $0.07 -- refinitiv ibes data.q3 adjusted non-gaap earnings per share $0.10.on november 4, 2019, company's board of directors authorized an increase of $20 million to company's share buyback program.qtrly earnings per share $0.03.
AMPH Ratings Summary
AMPH Quant Ranking